Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
58.95 USD | -0.54% | -4.77% | +48.26% |
Mar. 19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
Mar. 15 | Keros Therapeutics Shares Rise After FDA Fast Track Designation for Potential Anemia Drug | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.26% | 2.13B | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.89% | 21.66B | |
-18.35% | 20.77B | |
-8.65% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics Grants Hansoh Pharmaceutical Unit Exclusive License for KER-050